[1] LENDVAI G, SZEKERCZÉS T, ILLYÉS I, et al. Cholangiocarcinoma: classification, histopathology and molecular carcinogenesis[J]. Pathol Oncol Res, 2020, 26(1): 3-15. DOI: 10.1007/s12253-018-0491-8. [2] MAVROS M N, ECONOMOPOULOS K P, ALEXIOU V G, et al. Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. JAMA Surg, 2014,149(6):565-574. DOI: 10.1001/jamasurg.2013.5.5137. [3] YUSOFF A R, RAZAK M M, YOONG B K, et al. Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia[J]. World J Gastroenterol, 2012, 18(5): 458-465. DOI: 10.3748/wjg.v18.i5.458. [4] MAMONE G, MARRONE G, CARUSO S, et al. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase[J]. Abdom Imaging, 2015, 40(7): 2313-2322. DOI: 10.1007/s00261-015-0445-5. [5] KIM R, LEE J M, SHIN C I, et al. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging[J]. Eur Radiol, 2016, 26(6): 1808-1817. DOI: 10.1007/s00330-015-4005-8. [6] 邓启明, 杨新官, 黄文健, 等. 联合多种MRI参数预测肝内肿块型胆管细胞癌分化程度的研究[J]. 国际医学放射学杂志, 2020, 43(1): 17-20, 25. DOI: 10.19300/j.2020.L17254. [7] XING L H, ZHUO L Y, WANG J N, et al. Values of MRI imaging presentations in the hepatobiliary phase, DWI and T2WI sequences in predicting pathological grades of intrahepatic mass-forming cholangiocarcinoma[J]. Front Oncol, 2022, 12: 867702. DOI: 10.3389/fonc.2022.867702. [8] 中华医学会放射学分会腹部学组. 磁共振成像对比剂钆贝葡胺肝脏应用专家共识[J]. 中华肝胆外科杂志, 2017, 23(9): 577-584.. DOI: 10.3760/cma.j.issn.1007-8118.2017.09.001. [9] 单凯, 李职跃. 不同病理分级的肿块型肝内胆管细胞癌的影像学征象比较[J]. 放射学实践, 2018, 33(6): 582-586. DOI: 10.13609/j.cnki.1000-0313.2018.06.008. [10] 邓娟, 王俊, 李昇霖, 等. MRI常规检查联合扩散加权成像对不典型肝脓肿与肝内胆管细胞癌鉴别诊断的价值[J]. 磁共振成像, 2020, 11(12): 1119-1123. DOI: 10.12015/issn.1674-8034.2020.12.008. [11] 李杰, 赵勇. 高分化肿块型肝内胆管细胞癌的MRI特征[J]. 中国数字医学, 2019, 14(1): 47-49, 56. DOI: 10.3969/j.issn.1673-7571.2019.01.015. [12] MA X J, LIU L H, FANG J, et al. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma[J]. Cancer Imaging, 2020, 20: 40. DOI: 10.1186/s40644-020-00318-x. |